Vaginal health is a vital element of women’s overall well-being, and it encompasses factors such as pH balance, microbiota composition, hormonal influences, and hygiene practices. Maintaining a healthy vaginal environment is essential not only for comfort but also for preventing potential health issues. Understanding vaginal health and identifying relevant biomarkers can lead to innovative solutions. 

A company that embodies this principle is Evvy, who recently announced the closure of a $14M Series A funding round. Established in 2021, Evvy has committed itself to revolutionizing women’s healthcare through the strategic utilization of data and biomarkers, with an initial focus on the vaginal microbiome. Their AI-powered vaginal healthcare platform, centered around their proprietary vaginal microbiome test, is delivers tailored healthcare solutions for women and individuals with vaginas.

You’ve found some of our exclusive Inner Circle Content.

This article is only available for our Inner Circle Members. To read on: